("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology ... San Antonio Breast Cancer Symposium being held December 10-13, at ...
News
- Intensity Therapeutics, Inc. and The Swiss Group for Clinical Cancer Research SAKK ... - ABC4 Utah
- Medicenna Presents Preclinical Data on MDNA11 as First Step to S - GuruFocus
... Biotechnology MDNAF. Medicenna Presents Preclinical Data on MDNA11 ... San Antonio Breast Cancer Symposium (SABCS), the world's largest breast ...
- Medicenna Presents Preclinical Data on MDNA11 as First Step to Shrink Tumors Before ...
Medicenna Presents Preclinical Data on MDNA11 as First Step to Shrink Tumors Before Surgery and Prevent Metastasis at the 2024 San Antonio Breast ...
- Machine learning model predicts breast cancer treatment response - Medical Xpress
... San Antonio Breast Cancer Symposium (SABCS), held December 10–13, 2024. While the use of CDK4/6 inhibitors combined with endocrine therapy have ...
- Institutions statewide recognized by THECB for building a Talent Strong Texas
Digital Learning: The University of Texas at San Antonio, for online bachelor's degree programs; Transfer: Blinn College and Texas A&M University ...